Lv7
4020 积分 2023-10-01 加入
Efficacy and safety of obinutuzumab as rescue therapy for rituximab-resistant and rituximab-recurrent primary membranous nephropathy: a retrospective cohort study
2个月前
已完结
Obinutuzumab is effective for refractory primary membranous nephropathy
2个月前
已完结
Retrospective study of treatment effectiveness and remission predictors of obinutuzumab in primary membranous nephropathy
2个月前
已完结
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome
2个月前
已完结
Evaluation of efficacy of rituximab for membranous nephropathy: A systematic review and meta-analysis of 11 studies
2个月前
已完结
Real-World Long-term Comparisons of Rituximab versus Calcineurin Inhibitors for Membranous Nephropathy in the Cure Glomerulonephropathy Study
2个月前
已完结
Economic Evaluation of Rituximab Versus Corticosteroid‐Cyclophosphamide or Cyclosporine in Patients With Membranous Nephropathy in Republic of Korea
2个月前
已完结
Long-term outcomes of persistent disease and relapse in primary membranous nephropathy
2个月前
已完结
Obinutuzumab for PLA2R-associated membranous nephropathy
2个月前
已完结
The Cost-Effectiveness of Belimumab and Voclosporin for Patients with Lupus Nephritis in the United States
2个月前
已完结
皖公网安备34019202002308
